during her treatment, jeanne had tested negative for the pathogenic variant of the brca1 gene, which makes people more susceptible to breast and ovarian cancers. but it turned out that was a false negative. in october 2021, the family received a call that subsequent testing had shown jeanne was in fact a carrier of the pathogenic brca1 gene, which meant her close relatives could be carriers, too.
“genetic information that her sister left behind likely saved chrissie’s life,” mckendry wrote.
evert sent her blood for genetic testing, and had a pre-emptive hysterectomy in early december. by mid-december, she found out she had cancer, but that it had been removed during the hysterectomy and it hadn’t spread.
the next step is chemotherapy. after she undergoes those treatments, there’s a more than 90 per cent chance that her cancer will never return, mckendry wrote.
“as someone who has always had control over my life, i have no idea how i’ll respond to chemotherapy,” evert said. but the memory of her sister jeanne will help, she said. “when i go into chemo, she is my inspiration. i’ll be thinking of her. and she’ll get me through it.”
anyone born with ovaries is at risk of ovarian cancer,
ovarian cancer canada
points out. while there are very few regular symptoms, some warning signs may include bloating, fatigue, abdominal pain, changes in urinary or bowel habits and irregular periods.